Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.

Archives of neurology - 1 Feb 2001

Goetz C G, Burke P F, Leurgans S, Berry-Kravis E, Blasucci L M, Raman R, Zhou L

Abstract excerpt

BACKGROUND: Visual hallucinations in Parkinson disease (PD) occur in approximately one third of patients treated long-term with dopaminergic medications. In Alzheimer disease, hallucinations and psychosis have been linked to increased representations of B2/B2 homozyogotes for the dopamine receptor gene DRD1 and 1/1 or 2/2 homozygotes for DRD3. In addition, a previous study of PD patients with and without...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Hallucinations

Share to Parkinson Disease

Share to Polymorphism, Genetic

Share to Receptors, Dopamine

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 11176958
DOI: 10.1001/archneur.58.2.209

Genes

APOE
DRD3
DRD1
DRD2
DRD4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.PMID 11176958Read ↗

Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.Semantic proximity Read ↗

Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.Semantic proximity Read ↗

Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease.Semantic proximity Read ↗

Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.Semantic proximity Read ↗

Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.Semantic proximity Read ↗

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease.Semantic proximity Read ↗

Phenotypic associations of tau and ApoE in Parkinson's disease.Semantic proximity Read ↗

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's DiseaseSemantic proximity Read ↗

Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease.Semantic proximity Read ↗

PITX3 genotype and risk of dementia in Parkinson's disease: A population-based study.Semantic proximity Read ↗

Clinical phenotype of Parkinson disease dementia.Semantic proximity Read ↗

Clinical and Genetic Analysis of Psychosis in Parkinson's Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.